Application of antisense oligodeoxynucleotides (ODNs) for the intervention of kidney disease. Antisense ODNs for transforming growth factor-beta-suppressed glomerulosclerosis in experimental glomerulonephritis.
Imai
E
E
First Department of Medicine, Osaka University School of Medicine, Japan.
Isaka
Y
Y
Akagi
Y
Y
Arai
M
M
Moriyama
T
T
Takenaka
M
M
Kaneko
T
T
Horio
M
M
Ando
A
A
Orita
Y
Y
Kaneda
Y
Y
Ueda
N
N
Kamada
T
T
D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism; D005921:Glomerulonephritis / Q000188:drug therapy*; D006801:Humans; D007678:Kidney Glomerulus / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000378:metabolism / Q000627:therapeutic use*; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000032:analysis; D016212:Transforming Growth Factor beta / Q000235:genetics
D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta